Pharmanutra S.p.A. (PHN.MI)

EUR 53.2

(-1.48%)

Operating Expenses Summary of Pharmanutra S.p.A.

Pharmanutra S.p.A.'s latest annual operating expenses in 2023 was 25.58 Million EUR , up 444.52% from previous year.
Pharmanutra S.p.A.'s latest quarterly operating expenses in 2024 Q2 was 3.92 Million EUR , up 4031.63% from previous quarter.
Pharmanutra S.p.A. reported a annual operating expenses of 7.12 Million EUR in annual operating expenses 2022, up 10.68% from previous year.
Pharmanutra S.p.A. reported a annual operating expenses of 6.43 Million EUR in annual operating expenses 2021, down -18.48% from previous year.
Pharmanutra S.p.A. reported a quarterly operating expenses of 3.92 Million EUR for 2024 Q2, up 4031.63% from previous quarter.
Pharmanutra S.p.A. reported a quarterly operating expenses of 13.24 Million EUR for 2023 Q4, up 702.73% from previous quarter.

Annual Operating Expenses Chart of Pharmanutra S.p.A. (2023 - 2015)

Historical Annual Operating Expenses of Pharmanutra S.p.A. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	25.58 Million EUR	444.52%
2022	7.12 Million EUR	10.68%
2021	6.43 Million EUR	-18.48%
2020	7.89 Million EUR	39.02%
2019	5.68 Million EUR	122.12%
2018	2.55 Million EUR	-24.56%
2017	3.39 Million EUR	2.04%
2016	3.32 Million EUR	21.17%
2015	2.74 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	-98 Thousand EUR	-100.74%
2024 Q2	3.92 Million EUR	4031.63%
2023 Q4	13.24 Million EUR	702.73%
2023 FY	38.8 Million EUR	444.52%
2023 Q1	2.26 Million EUR	2.07%
2023 Q2	2.66 Million EUR	17.84%
2023 Q3	1.65 Million EUR	-38.18%
2022 FY	7.12 Million EUR	10.68%
2022 Q4	2.21 Million EUR	43.53%
2022 Q3	1.54 Million EUR	-15.47%
2022 Q2	1.82 Million EUR	19.31%
2022 Q1	1.53 Million EUR	-82.28%
2021 Q4	8.64 Million EUR	25.49%
2021 Q3	6.89 Million EUR	3.25%
2021 FY	6.43 Million EUR	-18.48%
2021 Q1	1.37 Million EUR	-45.64%
2021 Q2	6.67 Million EUR	384.4%
2020 Q4	2.53 Million EUR	56.48%
2020 FY	7.89 Million EUR	39.02%
2020 Q1	1.84 Million EUR	-11.58%
2020 Q2	1.9 Million EUR	3.48%
2020 Q3	1.62 Million EUR	-14.92%
2019 Q3	1.11 Million EUR	-57.64%
2019 Q4	2.08 Million EUR	86.14%
2019 FY	5.68 Million EUR	122.12%
2019 Q1	2.63 Million EUR	113.73%
2019 Q2	2.63 Million EUR	0.0%
2018 Q1	2.54 Million EUR	57.15%
2018 FY	2.55 Million EUR	-24.56%
2018 Q4	1.23 Million EUR	0.0%
2018 Q3	1.23 Million EUR	-51.48%
2018 Q2	2.54 Million EUR	0.0%
2017 FY	3.39 Million EUR	2.04%
2017 Q1	1.72 Million EUR	-3.37%
2017 Q2	1.72 Million EUR	0.0%
2017 Q3	1.61 Million EUR	-6.25%
2017 Q4	1.61 Million EUR	0.0%
2016 Q1	1.51 Million EUR	0.0%
2016 Q2	1.51 Million EUR	0.0%
2016 Q3	1.78 Million EUR	18.33%
2016 Q4	1.78 Million EUR	0.0%
2016 FY	3.32 Million EUR	21.17%
2015 FY	2.74 Million EUR	0.0%

Peer Operating Expenses Comparison of Pharmanutra S.p.A.

Name	Operating Expenses	Operating Expenses Difference